Kauzna A et al
When You Might Use the Shorter (2-Month) Timeline Your doctor might recommend the manufacturer-suggested 2-month washout if youre over 37 and age-related fertility decline is a pressing concern, your GLP-1 use was brief (only 8-12 weeks or less), youre taking liraglutide with its shorter half-life meaning faster clearance, your cycles regulated quickly and youre having regular ovulatory cycles by 6-8 weeks post-medication, or other individual factors in your case warrant it
Zeyner A et al

Target Consumer Segments Adults With Weight Management Goals (2550) : men and women seeking therapeutic supplementation for appetite regulation, fat metabolism, and sustainable weight loss Adults With Pre-diabetes Or Type 2 Diabetes (3060) : individuals requiring preventative and therapeutic support for blood sugar control and improved insulin sensitivity Obese And Overweight Consumers (2555) : adults addressing obesity-related health risks who benefit from GLP-1 booster supplementation for metabolic balance Seniors (55+) : older adults managing slower metabolism and cardiovascular health who require preventative supplementation for healthy aging and weight control Fitness Enthusiasts (2040) : active adults and athletes seeking appetite management, sustained energy, and recovery benefits from GLP-1 support Patients In Recovery : individuals overcoming chronic metabolic disorders or post-treatment fatigue who benefit from therapeutic supplementation for stabilization and resilience Regional Consumer Demand North America Market Insight : North America has a rapidly growing market for weight management and blood sugar control supplements, with a focus on natural, clinically-supported products

Because the stomach empties more slowly on these drugs, it can make it easier to vomit up food, says Keel
Both are approved and available in the US: Mounjaro for type 2 diabetes and Zepbound for chronic weight management